Factors Affecting Bisphosphonate Therapy Compliance In Patients With Osteogenesis Imperfecta
DOI:
https://doi.org/10.32539/bsm.v4i4.170Keywords:
Osteogenesis Imperfecta, Bisphosphonate, Compliance.Abstract
BACKGROUND: Osteogenesis imperfecta (OI) is a genetic disease with clinical manifestations in patients' bones. This study aims to investigate the factors that influence the compliance of bisphosphonate in patients with OI.
METHODS: A cross-sectional analysis method was conducted and data were obtained from questionnaires answered by OI patients that received bisphosphonate. The data obtained were statistically analyzed using chi-square.
RESULTS: There were 121 OI patients, age range 0-5 years (62%). Almost all patients have insurance from national health (BPJS). In this study, the average treatment compliance was 81.7%, and patients were reported to have good medication compliance of ≥80% of the treatment cycle, which was shown in 65 patients (53.7%). However, there is a relationship between parent education and treatment compliance (P = 0.046).
DISCUSSION: It is a measurement of behavior related to treatment recommendations by medical professionals. On the contrary, the level of non-compliance patients with chronic disease to treatment is quite high.
CONCLUSION: Good treatment compliance describes when the patient performs ≥80% of its cycle. Factors affecting it are the condition of the patient and the location of health services. Therefore, there is a relationship between compliance with the number of treatment cycles.
Authors
- Yoyos Ismiarto1*
- Firdaus Ramli F2
- Doddi Putra Pratama Sudjana2
- Naufal Chairulfatah2
- Wendy Yolanda Rossa2
- 1a:1:{s:5:"en_US";s:16:"RS Hasan Sadikin";}, Indonesia
- 2Resident of Orthopaedic and Traumatology, RS Hasan Sadikin, UNPAD, Bandung, Indonesia
Corresponding author Yoyos Ismiarto — yoyosismiartounpad@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.
- The non-exclusive right to publish the article and grant right to others.
- For the published article, the publisher applied for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
